These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28794137)

  • 21. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
    Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation".
    Huang G; Fadl SA; Sukhotski S; Matesan M
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):553-561. PubMed ID: 31853820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia.
    Kwon DH; Smedira NG; Rodriguez ER; Tan C; Setser R; Thamilarasan M; Lytle BW; Lever HM; Desai MY
    J Am Coll Cardiol; 2009 Jul; 54(3):242-9. PubMed ID: 19589437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
    Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging.
    Bicudo LS; Tsutsui JM; Shiozaki A; Rochitte CE; Arteaga E; Mady C; Ramires JA; Mathias W
    Echocardiography; 2008 Aug; 25(7):717-26. PubMed ID: 18445062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-wave alternans and left ventricular wall thickness in predicting arrhythmic risk in patients with hypertrophic cardiomyopathy.
    Puntmann VO; Yap YG; McKenna W; Camm J
    Circ J; 2010 Jun; 74(6):1197-204. PubMed ID: 20467148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging.
    Losi MA; Imbriaco M; Canciello G; Pacelli F; Di Nardo C; Lombardi R; Izzo R; Mancusi C; Ponsiglione A; Dell'Aversana S; Cuocolo A; de Simone G; Trimarco B; Barbato E
    J Cardiovasc Transl Res; 2020 Apr; 13(2):238-244. PubMed ID: 31489577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Velocity vector imaging in the measurement of left ventricular myocardial mechanics on cardiac magnetic resonance imaging: correlations with echocardiographically derived strain values.
    Williams LK; Urbano-Moral JA; Rowin EJ; Jamorski M; Bruchal-Garbicz B; Carasso S; Pandian NG; Maron MS; Rakowski H
    J Am Soc Echocardiogr; 2013 Oct; 26(10):1153-1162. PubMed ID: 23876996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic concordance of echocardiography and cardiac magnetic resonance-based tissue tracking for differentiating constrictive pericarditis from restrictive cardiomyopathy.
    Amaki M; Savino J; Ain DL; Sanz J; Pedrizzetti G; Kulkarni H; Narula J; Sengupta PP
    Circ Cardiovasc Imaging; 2014 Sep; 7(5):819-27. PubMed ID: 25107553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delay enhancement patterns in apical hypertrophic cardiomyopathy by phase-sensitive inversion recovery sequence.
    Guo ZY; Chen J; Liang QZ; Liao HY; Fu SX; Tang QY; Chen CX; Han XJ; Gao F
    Asian Pac J Trop Med; 2012 Oct; 5(10):828-30. PubMed ID: 23043925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Ventricular Septal Measurements in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy Using Multimodality Imaging and Implications for Diagnosis and Management.
    Phelan D; Sperry BW; Thavendiranathan P; Collier P; Popović ZB; Lever HM; Smedira NG; Desai MY
    Am J Cardiol; 2017 May; 119(10):1656-1662. PubMed ID: 28363351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of strain by feature tracking and clinical outcome in children, adolescents, and young adults with hypertrophic cardiomyopathy.
    Smith BM; Dorfman AL; Yu S; Russell MW; Agarwal PP; Ghadimi Mahani M; Lu JC
    Am J Cardiol; 2014 Oct; 114(8):1275-80. PubMed ID: 25159233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional echocardiography for the assessment of left ventricular geometry and papillary muscle morphology in hypertrophic cardiomyopathy.
    Erden M; van Velzen HG; Menting ME; van den Bosch AE; Ren B; Michels M; Vletter WB; van Domburg RT; Schinkel AFL
    J Ultrasound; 2018 Mar; 21(1):17-24. PubMed ID: 29374400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left Ventricular Mass Quantification by Two-Dimensional Echocardiography in a Pediatric Population: Correlation with Cardiac Magnetic Resonance Imaging.
    Chu BJ; Lee T; Gilbreth JG; Nielsen JC; Ludomirsky A; Tretter JT; Bhatla P
    Pediatr Cardiol; 2019 Feb; 40(2):412-420. PubMed ID: 30310940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.